LAPOROLIMUS

UNII:	F5041W3RVA
Type:	INGREDIENT SUBSTANCE
Formula:	C₅₈H₈₉NO₁₄
Preferred Substance Name:	LAPOROLIMUS
InChIKey:	CFHQWCVHPJFPBS-IMPNTQJQSA-N
GSRS Full Record:	F5041W3RVA i

1504576-27-5
(1R,2R,4S)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-methyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0<sup>4,9</sup>]hexatriaconta-16,24,26,28-tetraene-12-yl]propyl}-2-methoxycyclohexylcyclohexanecarboxylate
CRC-015
LAPOROLIMUS [USAN]
Laporolimus
Rapamycin, 42-cyclohexanecarboxylate
[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] cyclohexanecarboxylate
laporolimus [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LAPOROLIMUS

Synonyms and Mappings

Resources